Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

MDCU MedUMORE: a national digital platform for equitable and lifelong medical education in Thailand and beyond.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Enlarged perivascular spaces in subcortical white matter are linked to amyloid-tau depositions and cognitive decline: Data from a memory clinic in Thailand.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Slow-inactivated sodium channels as a therapeutic target in trigeminal neuralgia: evidence from a systematic review and meta-analysis of lacosamide.

Journal of oral & facial pain and headache·2026
Same author

Associations between oral migraine preventive regimens and CGRP monoclonal antibody initiation: real-world evidence from a resource-limited setting.

BMC neurology·2026
Same author

AI-powered simulated patients with automated feedback for enhancing headache history-taking skills: a convergent mixed-methods study.

BMC medical education·2026
Same author

Diagnostic and prognostic value of blood neurofilament light chain in ischemic stroke: an individual patient data meta-analysis.

Journal of neurology·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Kittithatch Booncharoen1,2,3, Akarin Hiransuthikul3,4, Yuttachai Likitjaroen2,3

  • 1Neurology Center, Phyathai 1 Hospital, Bangkok, Rachathewi, Thailand.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

这就是阿尔茨海默病的原因.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经学 神经学
  • 生物标志物研究 生物标志物研究
  • 神经成像是一种神经成像.

背景情况:

  • 阿尔茨海默病 (AD) 生物标志物如血液p-Tau,tau PET和粉样PET预测AD病理.
  • 神经炎症标志物GFAP和NfL也至关重要.
  • 它们对轻度认知障碍 (MCI) 和轻度痴呆症短期下降的预测潜力需要进一步探索.

研究的目的:

  • 调查AD和神经炎症生物标志物对MCI和轻度痴呆症患者短期认知和功能衰退的预测价值.
  • 为了比较各种生物标志物的预后能力,包括Tau PET,粉体PET,血p-Tau变体,GFAP和NfL.

主要方法:

  • 从泰国曼谷的一家记忆诊所招募了患有MCI和轻度痴呆症的参与者.
  • 在基线评估的Tau PET,粉胺PET,血p-Tau-181,p-Tau-217,GFAP和NfL.
  • 在基线和24个月后的随访中使用MoCA和CDR-SB评估认知和功能能力,根据得分变化定义进展者.

主要成果:

  • 与非进展者相比,进展者显示出粉样PET,Tau PET SUVR (布拉克阶段3-4),血p-Tau-217和GFAP的中位数显著更高.
  • 陶 PET SUVR显示了24个月进展的最高预后值 (AUC 0.84),其次是血GFAP (AUC 0.78) 和血p-Tau-217 (AUC 0.77).
  • 血p-Tau-181和NfL水平在进展者和非进展者之间没有显著差异.

结论:

  • 布拉克阶段3-4的Tau PET SUVR是短期认知和功能衰退的强有力的预测因素.
  • 血p-Tau-217显示出诊断和预后实用性.
  • 血GFAP在预测该队列的短期进展方面比血NfL更有效.